Related references
Note: Only part of the references are listed.Understanding FDA Regulatory Requirements for Investigational New Drug Applications for Sponsor-Investigators
M. E. Blair Holbein
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Michael J. Waring et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Exploratory toxicology as an integrated part of drug discovery. Part II: Screening strategies
Jorrit J. Hornberg et al.
DRUG DISCOVERY TODAY (2014)
A modern in vivo pharmacokinetic paradigm: combining snapshot, rapid and full PK approaches to optimize and expedite early drug discovery
Chun Li et al.
DRUG DISCOVERY TODAY (2013)
Safety pharmacology - Current and emerging concepts
Junnat Hamdam et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Lung function measurements in rodents in safety pharmacology studies
Heinz Gerd Hoymann
FRONTIERS IN PHARMACOLOGY (2012)
On the relationship between block of the cardiac Na+ channel and drug-induced prolongation of the QRS complex
A. R. Harmer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety
Nicholas A. Meanwell
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Comparisons of 3 plethysmography techniques for rodent pulmonary function assessment using ponemah waveforms analysis
David V. Gauvin et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2011)
Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes
Stefan R. Braam et al.
STEM CELL RESEARCH (2010)
Exploratory Safety Pharmacology: a new safety paradigm to de-risk drug candidates prior to selection for regulatory science investigations
Icilio Cavero
EXPERT OPINION ON DRUG SAFETY (2009)
The fentanyl/etomidate-anaesthetised beagle (FEAB) dog: A versatile in vivo model in Cardiovascular Safety Research
Bruno Van Deuren et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2009)
Blockade of the IKs potassium channel: An overlooked cardiovascular liability in drug safety screening?
Rob Towart et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2009)
Principles of safety pharmacology
M. K. Pugsley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
hERG channel trafficking: novel targets in drug-induced long QT syndrome
A. Dennis et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Integrating in vitro ADMET data through generic physiologically based pharmacokinetic models
David E. Leahy
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Preclinical pharmacokinetics: An approach towards safer and efficacious drugs
SS Singh
CURRENT DRUG METABOLISM (2006)
The L-type calcium channel in the heart: the beat goes on
I Bodi et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Predicting in vivo drug interactions from in vitro drug discovery data
LC Wienkers et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Refinements in telemetry procedures - Seventh report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement, part A
DB Morton et al.
LABORATORY ANIMALS (2003)
Medical progress: Drug-induced hepatotoxicity
WM Lee
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The conduct of in vitro and in vivo drug-drug interaction studies: A Pharmaceutical Research and Manufacturers of America (PhRMA) perspective
TD Bjornsson et al.
DRUG METABOLISM AND DISPOSITION (2003)
Long QT syndrome and anaesthesia
NA Wisely et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2002)
Integration of safety pharmacology endpoints into toxicology studies
J Luft et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2002)
Estimating the starting dose for entry into humans: principles and practice
BG Reigner et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Share Paper
